ALK-Abelló A/S

(PINK:AKBLF)

Latest On ALK-Abelló A/S (AKBLF):

Date/Time Type Description Signal Details
2022-11-10 10:28 ESTNewsALK-Abelló A/S GAAP EPS of DKK 0.23, revenue of DKK 1.06BN/A
2022-08-11 20:41 ESTNewsALK-Abelló A/S reports Q2 resultsN/A
2022-05-12 09:43 ESTNewsALK-Abelló A/S GAAP EPS of $0.70, revenue of $1.16B; reaffirms FY22 guidanceN/A
2022-02-08 10:46 ESTNewsALK-Abelló A/S reports Q4 resultsN/A
2021-05-05 08:46 ESTNewsALK-Abelló A/S reports Q1 resultsN/A
2021-03-18 14:53 ESTEarnings EstimateAn EPS average of -$0.10 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-18 14:53 ESTEarnings EstimateAn EPS average of $1.14 is estimated for the quarter ending on March 31, 2021.Buy
2021-03-18 14:53 ESTEarnings EstimateAn EPS average of $6.13 is estimated for the 2022 year.Buy
2021-02-12 05:43 ESTFinancialsCompany financials have been released.Neutral
2020-12-04 18:21 ESTFinancialsCompany financials have been released.Neutral
2020-11-26 23:41 ESTFinancialsCompany financials have been released.Neutral
2020-11-14 06:57 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 07:55 ESTNewsALK-Abelló A/S reports Q3 resultsN/A
2020-11-08 02:37 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 18:58 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 15:49 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 08:17 ESTFinancialsCompany financials have been released.Neutral
2020-08-15 02:49 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 11:52 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 15:30 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 19:40 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 07:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 23:53 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 17:07 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 15:29 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 20:20 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 11:42 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 19:22 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 03:13 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 15:15 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 07:25 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 08:58 ESTFinancialsCompany financials have been released.Neutral
2020-06-02 10:44 ESTEarnings EstimateAn EPS average of -$0.76 is estimated for the quarter ending on September 30, 2020.Sell
2020-05-27 08:03 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 03:43 ESTFinancialsCompany financials have been released.Neutral
2020-05-16 02:55 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 08:21 ESTFinancialsCompany financials have been released.Neutral
2020-05-02 22:54 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 19:12 ESTFinancialsCompany financials have been released.Neutral
2020-04-20 06:59 ESTFinancialsCompany financials have been released.Neutral
2020-04-09 23:08 ESTFinancialsCompany financials have been released.Neutral
2020-04-03 23:36 ESTFinancialsCompany financials have been released.Neutral
2020-03-25 23:04 ESTFinancialsCompany financials have been released.Neutral
2020-02-18 01:56 ESTFinancialsCompany financials have been released.Neutral
2020-02-14 15:55 ESTEarnings EstimateAn EPS average of $2.67 is estimated for the 2021 year.Buy
2020-02-14 15:55 ESTEarnings EstimateAn EPS average of $0.01 is estimated for the 2020 year.Buy
2020-02-14 15:55 ESTEarnings EstimateAn EPS average of $0.09 is estimated for the quarter ending on June 30, 2020.Buy
2020-02-14 15:55 ESTEarnings EstimateAn EPS average of $0.79 is estimated for the quarter ending on March 31, 2020.Buy

About ALK-Abelló A/S (AKBLF):

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. Its products include GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.

See Advanced Chart

General

  • Name ALK-Abelló A/S
  • Symbol AKBLF
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 2,447
  • Fiscal Year EndDecember
  • Web URLhttp://www.alk.net
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 7.64
  • Price/Book (Most Recent Quarter) 8.41
  • Enterprise Value Revenue 1.25
  • Enterprise Value EBITDA 11.51
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $1.61
  • Next Year EPS Estimate $6.13
  • Profit Margin 1%
  • Return on Assets 2%
  • Return on Equity 1%
  • Revenue Per Share $0
  • Gross Profit 2.05 billion
  • Quarterly Earnings Growth 12.2%
View More

Highlights

  • Market Capitalization 4.15 billion
  • PEG Ratio 779.93
View More

Share Statistics

  • Shares Outstanding 9.89 million
  • Shares Float 6.43 million
  • % Held by Insiders <1%
  • % Held by Institutions 61.43%
View More

Technicals

  • Beta 0.19
  • 52 Week High $418
  • 52 Week Low $259.5
  • 50 Day Moving Average 373.2
  • 200 Day Moving Average 287.52
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date 2017-03-16
  • Dividend Yield 0%
View More

ALK-Abelló A/S (AKBLF) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

ALK-Abelló A/S (AKBLF) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31$N/A-$0.45$0.58-177.59%
2020-09-302020-12-31$N/A-$0.47-$3.3085.62%
2020-06-302020-09-30$N/A-$0.28-$2.3087.68%
2020-03-312020-06-30$956 million-$0.14$3.30-104.11%
2019-12-312020-03-31$132.52 million$1.15-$3.40133.9%
2019-09-302019-12-31$107.89 million-$0.18-$2.6193.15%
2019-06-302019-09-30$118.69 million-$0.19-$2.2891.76%
2019-03-312019-06-30$130.23 million-$0.94$2.40-139.36%
2018-12-312019-03-31$120.87 million$0.62-$2.12129.06%
2018-09-302018-12-31$102.64 million-$20.13-$6.85-193.83%
2018-06-302018-09-30$111.68 million-$0.37-$8.0295.34%
2018-03-312018-06-30$124.19 million-$0.25-$7.3696.59%
2017-12-312018-03-31$123.03 million$0.36-$2.02117.62%
2017-09-302017-12-31$105.14 million-$2.36-$1.47-60.63%
2017-06-302017-08-16$691 million-$0.02$1.90-100.79%
2017-03-312017-06-30-$0.02
2016-12-312017-03-31$0.03$3.30-99.12%
2016-09-302016-12-31$0.51$2.80-81.83%
2016-06-302016-09-30$0.60$4.70-87.16%
2016-03-312016-06-30$1.04$9.55-89.06%
2015-12-312016-03-31$1.83
2015-09-302015-12-31$2.01-$0.73374.73%
2015-06-302015-09-30$0.90-$0.80212.18%
2015-03-312015-06-30$0.75
2014-12-312015-03-31$1.30$5.74-77.35%
2014-09-302014-12-31$0.26-$0.96127.48%
2014-06-302014-09-30$0.45$1.09-59.09%
2014-03-312014-06-30$0.57$6.63-91.33%
2013-12-312014-03-31$2.01$3.21-37.34%
2013-09-302013-12-31$0.75$0.00
2013-06-302013-09-30$0.17$0.00
2013-03-312013-06-30-$0.54$0.00
2012-12-312013-03-31$0.74$0.00
2012-09-302012-12-31-$0.27$0.00
2012-06-302012-09-30$0.99$0.00
2012-03-312012-06-30-$0.47$0.00
2011-12-312012-03-31$0.73$0.00
2011-09-302011-12-31$0.34$0.00
2011-06-302011-09-30$0.75$0.00
2011-03-312011-06-30$0.26$0.00
2010-12-312011-03-31$2.44$0.00
2010-09-302010-12-31$0.72$0.00

ALK-Abelló A/S (AKBLF) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

ALK-Abelló A/S (AKBLF) Chart:

ALK-Abelló A/S (AKBLF) News:

Below you will find a list of latest news for ALK-Abelló A/S (AKBLF) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

ALK-Abelló A/S (AKBLF) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

ALK-Abelló A/S (AKBLF) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link